These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8642677)

  • 21. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
    Murray RJ; Brooks JM; Rickinson AB; Rowe M
    Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
    J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
    J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E; Guerrini R; Giori B; Borghi M; Marastoni M; Tomatis R; Traniello S; Masucci MG; Gavioli R
    Clin Exp Immunol; 1996 Aug; 105(2):369-75. PubMed ID: 8706347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
    J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.
    Kienzle N; Sculley TB; Poulsen L; Buck M; Cross S; Raab-Traub N; Khanna R
    J Virol; 1998 Aug; 72(8):6614-20. PubMed ID: 9658107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length.
    Green KJ; Miles JJ; Tellam J; van Zuylen WJ; Connolly G; Burrows SR
    Eur J Immunol; 2004 Sep; 34(9):2510-9. PubMed ID: 15307183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.
    Kerr BM; Kienzle N; Burrows JM; Cross S; Silins SL; Buck M; Benson EM; Coupar B; Moss DJ; Sculley TB
    J Virol; 1996 Dec; 70(12):8858-64. PubMed ID: 8971014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus.
    Apolloni A; Moss D; Stumm R; Burrows S; Suhrbier A; Misko I; Schmidt C; Sculley T
    Eur J Immunol; 1992 Jan; 22(1):183-9. PubMed ID: 1370413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
    Gavioli R; Vertuani S; Masucci MG
    Int J Cancer; 2002 Oct; 101(6):532-8. PubMed ID: 12237893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants.
    Khanna R; Burrows SR; Silins SL; Moss DJ; Poulsen LM; Burrows JM
    J Virol; 1996 Oct; 70(10):7306-11. PubMed ID: 8794388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH; Fleischer B
    Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
    Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
    J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.